ClinIQ introduces VirusIQ remote screening to support safer air travel during COVID-19

ClinIQ Healthcare´s public health project VirusIQ, has announced the introduction of a digital, remote screening test as an end-to-end solution to support safer air travel amidst COVID-19, the company said.

To safely return to air travel requires risk mitigation and customer confidence. Screening procedures must be implemented at least 14 days prior to travel, and travelers must be monitored prior to and after travel. VirusIQ ensures partnering airlines are at the front of the queue when it comes to safety.

The VirusIQ mobile application (available on Android & iOS) helps detect, prevent and contain the spread of viruses. For airlines, VirusIQ enables passengers to perform screening tests up to 14 days prior to check-in. Users can screen for COVID-19 in under 5 minutes in the convenience and privacy of their chosen location, enabling airlines to resume business activity safely. VirusIQ also performs ancillary services, offering contact tracing, telemedicine, assisted quarantine and digital health passes.

In accordance with FAA & TSA guidelines, VirusIQ does not introduce any process or equipment that might endanger airline passengers. Its dedicated team of clinical trial investigators is working to validate screening processes in every country to cater for variations in a global population.

VirusIQ, a screening sherpa, guides safe access to healthcare and informs community members of their risk, helping reduce viral spread.